XNCR
Xencor Inc
NASDAQ · Healthcare · Biotechnology · US
$24.72
+0.53%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.35
- Revenue estimate
- $59.1M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.29
- EPS estimate
- -$0.80
- Revenue actual
- $51.2M
- Revenue estimate
- $18.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +19.0%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $32
- PT range
- $20 – $46
- Analysts
- 7
6 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.80 | -$0.29 | Beat 63.82% | $51.2M |
| May 12, 2026 | -$0.65 | -$1.71 | Miss -163.08% | $4.5M |
| Feb 25, 2026 | -$0.66 | -$0.09 | Beat 86.36% | $28.2M |
| Nov 5, 2025 | -$0.72 | -$0.08 | Beat 88.89% | $21.0M |
| Aug 6, 2025 | -$0.78 | -$0.41 | Beat 47.44% | $43.6M |
| May 7, 2025 | -$0.63 | -$0.66 | Miss -4.76% | $32.7M |
| Feb 27, 2025 | -$0.81 | -$0.62 | Beat 23.46% | $70.0M |
| May 9, 2024 | -$0.76 | -$1.11 | Miss -46.05% | $12.8M |
| Feb 27, 2024 | $0.36 | -$0.31 | Miss -186.11% | $44.7M |
| Aug 3, 2023 | -$0.91 | -$0.37 | Beat 59.34% | $45.5M |
| Feb 23, 2023 | -$0.83 | -$0.20 | Beat 75.90% | $21.6M |
| Aug 3, 2022 | -$0.45 | -$0.57 | Miss -26.67% | $30.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026